Bendeka Interactions
There are 296 drugs known to interact with Bendeka (bendamustine), along with 4 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 48 are major, and 248 are moderate.
- View all 296 medications that may interact with Bendeka
- View Bendeka alcohol/food interactions (2)
- View Bendeka disease interactions (4)
Most frequently checked interactions
View interaction reports for Bendeka (bendamustine) and the medicines listed below.
- abacavir
- Abraxane (paclitaxel protein-bound)
- Adderall XR (amphetamine / dextroamphetamine)
- Adriamycin (doxorubicin)
- Aggrastat (tirofiban)
- allopurinol
- aluminum hydroxide / magnesium trisilicate
- ascorbic acid
- BeneFix (coagulation factor ix)
- bevacizumab
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Blenoxane (bleomycin)
- bleomycin
- Bosulif (bosutinib)
- bupropion
- BuSpar (buspirone)
- carboplatin
- carvedilol
- Cayston (aztreonam)
- chlordiazepoxide
- cisplatin
- Coreg (carvedilol)
- Cotellic (cobimetinib)
- Cytoxan (cyclophosphamide)
- Cytoxan Lyophilized (cyclophosphamide)
- Dacogen (decitabine)
- Rebinyn (coagulation factor ix)
- Rituxan (rituximab)
- Rituxan Hycela (hyaluronidase / rituximab)
- Sandimmune (cyclosporine)
Bendeka alcohol/food interactions
There are 2 alcohol/food interactions with Bendeka (bendamustine).
Bendeka disease interactions
There are 4 disease interactions with Bendeka (bendamustine) which include:
Report options
More about Bendeka (bendamustine)
- Bendeka consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: alkylating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Venetoclax
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or ...
Vincristine
Vincristine systemic is used for acute lymphocytic leukemia, acute myeloid leukemia, anaplastic ...
Cyclophosphamide
Cyclophosphamide systemic is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia ...
Rituximab
Rituximab infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Methotrexate
Methotrexate is used to treat certain types of cancer of the breast, skin, head and neck, or lung ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
